Hot Penny Stocks (FONR, ICGN, NBY)

Shares of Fonar Corporation (NASDAQ: FONR) are seeing a huge rally today. The stock opened at $1.52 and reached an intra-day high of $1.85. It was up 18.18% to $1.69, at last check, on above average volume of 129,015.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

The Fonar Corporation stock has a 52-week range of $1.19-$4.60. It has a 50-day moving average of $1.54 and a 200-day moving average of $1.76. The support level for the stock is at $1.40. The stock has breached its resistance level of $1.55 today.

Based in Melville, New York, Fonar Corporation is engaged in tow business areas; medical equipment segment, and physician management and diagnostic services segment.

Shares of Icagen Inc. (NASDAQ: ICGN) are climbing in trading today. The stock opened at $0.32 today. Currently, it is up 9.38% to $0.350, which is also its intra-day high, on volume of 19,900.

The Icagen Inc. stock has a 52-week range of $0.25-$1.59. It has a 50-day moving average of $0.44 and a 200-day moving average of $0.60. The support level for the stock is at $0.31. The stock has breached its resistance level of $0.34 today.

Icagen Inc. is a Durham, North Carolina-based biopharmaceutical company. The company seeks to discover, develop and commercialize orally administered small molecule drugs that modulate ion channel targets.

Subscribe to daily free stock newsletter by visiting:  http://www.pennystockpickreport.com/

Shares of NovaBay Pharmaceuticals Inc. (AMEX: NBY) are soaring in trading today. The stock opened at $2.15 and reached an intra-day high of $2.29. It was up 8.96% to $2.20, at last check, on above average volume of 113,389.

The NovaBay Pharmaceuticals Inc. stock has a 52-week range of $1.62-$2.71. It has a 50-day moving average of $2.26 and a 200-day moving average of $2.14. The support level for the stock is at $1.92. The stock has breached its resistance level of $2.10 today.

NovaBay Pharmaceuticals Inc. is an Emeryville, California-based clinical-stage pharmaceutical company. The company today announced that its non-antibiotic anti-infective has been successful in Phase 2 skin infection trial.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot Penny stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.